vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and OLIN Corp (OLN). Click either name above to swap in a different company.

OLIN Corp is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.6× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -8.6%, a 14.1% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -0.4%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 0.9%).

Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.

ECG vs OLN — Head-to-Head

Bigger by revenue
OLN
OLN
1.6× larger
OLN
$1.7B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+33.5% gap
ECG
33.2%
-0.4%
OLN
Higher net margin
ECG
ECG
14.1% more per $
ECG
5.5%
-8.6%
OLN
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
0.9%
OLN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECG
ECG
OLN
OLN
Revenue
$1.0B
$1.7B
Net Profit
$55.3M
$-143.2M
Gross Margin
11.6%
1.9%
Operating Margin
6.8%
-9.4%
Net Margin
5.5%
-8.6%
Revenue YoY
33.2%
-0.4%
Net Profit YoY
60.4%
-1517.8%
EPS (diluted)
$1.09
$-1.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
OLN
OLN
Q4 25
$1.0B
$1.7B
Q3 25
$986.8M
$1.7B
Q2 25
$921.5M
$1.8B
Q1 25
$826.6M
$1.6B
Q4 24
$759.6M
$1.7B
Q3 24
$761.0M
$1.6B
Q2 24
$703.4M
$1.6B
Q1 24
$625.7M
$1.6B
Net Profit
ECG
ECG
OLN
OLN
Q4 25
$55.3M
$-143.2M
Q3 25
$57.0M
$43.7M
Q2 25
$52.8M
$-2.8M
Q1 25
$36.7M
$1.2M
Q4 24
$34.5M
$10.1M
Q3 24
$41.8M
$-25.2M
Q2 24
$39.0M
$72.3M
Q1 24
$28.2M
$47.8M
Gross Margin
ECG
ECG
OLN
OLN
Q4 25
11.6%
1.9%
Q3 25
12.6%
10.7%
Q2 25
13.0%
7.9%
Q1 25
11.2%
9.0%
Q4 24
11.4%
9.4%
Q3 24
11.8%
8.5%
Q2 24
12.6%
14.5%
Q1 24
11.9%
12.7%
Operating Margin
ECG
ECG
OLN
OLN
Q4 25
6.8%
-9.4%
Q3 25
7.3%
4.8%
Q2 25
7.9%
2.0%
Q1 25
6.2%
2.7%
Q4 24
6.1%
2.8%
Q3 24
7.1%
1.0%
Q2 24
7.3%
8.3%
Q1 24
6.2%
5.9%
Net Margin
ECG
ECG
OLN
OLN
Q4 25
5.5%
-8.6%
Q3 25
5.8%
2.6%
Q2 25
5.7%
-0.2%
Q1 25
4.4%
0.1%
Q4 24
4.5%
0.6%
Q3 24
5.5%
-1.6%
Q2 24
5.5%
4.4%
Q1 24
4.5%
2.9%
EPS (diluted)
ECG
ECG
OLN
OLN
Q4 25
$1.09
$-1.25
Q3 25
$1.11
$0.37
Q2 25
$1.03
$-0.01
Q1 25
$0.72
$0.01
Q4 24
$0.68
$0.10
Q3 24
$0.82
$-0.21
Q2 24
$0.76
$0.62
Q1 24
$0.55
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
OLN
OLN
Cash + ST InvestmentsLiquidity on hand
$167.6M
Total DebtLower is stronger
$281.5M
$2.8B
Stockholders' EquityBook value
$629.8M
$1.8B
Total Assets
$1.7B
$7.3B
Debt / EquityLower = less leverage
0.45×
1.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
OLN
OLN
Q4 25
$167.6M
Q3 25
Q2 25
Q1 25
Q4 24
$175.6M
Q3 24
$553.0K
Q2 24
Q1 24
Total Debt
ECG
ECG
OLN
OLN
Q4 25
$281.5M
$2.8B
Q3 25
$285.1M
$3.0B
Q2 25
$288.6M
$3.0B
Q1 25
$292.1M
$3.0B
Q4 24
$295.6M
$2.7B
Q3 24
$2.8B
Q2 24
$2.8B
Q1 24
$2.7B
Stockholders' Equity
ECG
ECG
OLN
OLN
Q4 25
$629.8M
$1.8B
Q3 25
$573.0M
$2.0B
Q2 25
$514.4M
$2.0B
Q1 25
$460.2M
$2.0B
Q4 24
$422.6M
$2.0B
Q3 24
$453.3M
$2.1B
Q2 24
$490.0M
$2.1B
Q1 24
$464.3M
$2.2B
Total Assets
ECG
ECG
OLN
OLN
Q4 25
$1.7B
$7.3B
Q3 25
$1.6B
$7.6B
Q2 25
$1.5B
$7.7B
Q1 25
$1.4B
$7.7B
Q4 24
$1.3B
$7.6B
Q3 24
$1.3B
$7.5B
Q2 24
$7.7B
Q1 24
$7.6B
Debt / Equity
ECG
ECG
OLN
OLN
Q4 25
0.45×
1.55×
Q3 25
0.50×
1.52×
Q2 25
0.56×
1.52×
Q1 25
0.63×
1.50×
Q4 24
0.70×
1.34×
Q3 24
1.34×
Q2 24
1.31×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
OLN
OLN
Operating Cash FlowLast quarter
$48.2M
$321.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
OLN
OLN
Q4 25
$48.2M
$321.2M
Q3 25
$76.2M
$26.7M
Q2 25
$25.3M
$212.3M
Q1 25
$7.1M
$-86.0M
Q4 24
$141.7M
Q3 24
$78.9M
$189.9M
Q2 24
$90.6M
Q1 24
$21.9M
$81.0M
Free Cash Flow
ECG
ECG
OLN
OLN
Q4 25
$23.5M
Q3 25
$65.7M
$-44.4M
Q2 25
$12.3M
Q1 25
$-11.4M
$-147.4M
Q4 24
$90.7M
Q3 24
$60.9M
$146.6M
Q2 24
$34.1M
Q1 24
$12.6M
$36.7M
FCF Margin
ECG
ECG
OLN
OLN
Q4 25
2.3%
Q3 25
6.7%
-2.6%
Q2 25
1.3%
Q1 25
-1.4%
-9.0%
Q4 24
5.4%
Q3 24
8.0%
9.2%
Q2 24
2.1%
Q1 24
2.0%
2.2%
Capex Intensity
ECG
ECG
OLN
OLN
Q4 25
2.4%
Q3 25
1.1%
4.2%
Q2 25
1.4%
Q1 25
2.2%
3.7%
Q4 24
3.1%
Q3 24
2.4%
2.7%
Q2 24
3.4%
Q1 24
1.5%
2.7%
Cash Conversion
ECG
ECG
OLN
OLN
Q4 25
0.87×
Q3 25
1.34×
0.61×
Q2 25
0.48×
Q1 25
0.19×
-71.67×
Q4 24
14.03×
Q3 24
1.89×
Q2 24
1.25×
Q1 24
0.77×
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

OLN
OLN

Chlorinechlorinederivativesandothercoproducts$456.2M27%
Causticsoda$400.2M24%
Militaryandlawenforcement$304.6M18%
Epoxyresins$194.9M12%
Aromaticsandallylics$164.4M10%
Commercial$144.8M9%

Related Comparisons